KF-21213

N/A

Report date: 2023/05/17 08:52:02

Base Information

Drug NameKF-21213

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugs

Mechanisms of ActionPositron-emission tomography enhancersAdenosine A2a receptor antagonists

TargetsAdenosine A2a receptor

Therapy Area/IndicationsNervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKyowa Hakko

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesKyowa Hakko

Active IndicationsN/A

Inactive IndicationsNervous System Diseases

ATC CodeN/A